Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 13.02.2012Börsentäglich über 11.000 News von 420 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

Aktuelle News zu Aktien im NASDAQ Biotech

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
00:0781
FOLGENDE WERTPAPIERE WERDEN AM 13.02.2012 EX DIVIDENDE GEHANDELT. THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 13.02.2012. INSTR EXCH ISIN INSTRUMENT NAME DIVIDEND AMOUNT A1I XFRA US04315B1070...
Mehr lesen zu:
XFRA DIVIDEND INFORMATION - 13.02.2012 - 3
00:0771
FOLGENDE WERTPAPIERE WERDEN AM 13.02.2012 EX DIVIDENDE GEHANDELT. THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 13.02.2012. INSTR EXCH ISIN INSTRUMENT NAME DIVIDEND AMOUNT LLY XETR US5324571083...
Mehr lesen zu:
XETR DIVIDEND INFORMATION - 13.02.2012 - 2
12.02. 5
12.02. 7
12.02. 9
11.02. -
11.02. 3
11.02. -
11.02. 5
11.02. 2
11.02. -
11.02. -
10.02. 244
CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced Friday that a jury has rendered an unfavorable verdict in a patent infringement lawsuit filed by Sunovion Pharmaceuticals Inc., f/k/a Sepracor...
Mehr lesen zu:
Jury Rules Against Mylan In Sunovion Pharma Patent Litigation
10.02. 2
10.02. 152
PITTSBURGH, Feb. 10, 2012 /PRNewswire/ --Mylan Inc. (Nasdaq: MYL) today announced that a jury has rendered an unfavorable verdict in a patent infringement lawsuit filed by Sunovion...
Mehr lesen zu:
Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution
10.02. 1
10.02. 1
10.02. 29
SAN FRANCISCO, CA -- (Marketwire) -- 02/10/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following investor conferences in February: Patrick Machado, chief...
Mehr lesen zu:
Medivation Announces Participation at Upcoming Investor Conferences
10.02. 44
Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey, Ph.D., the company's president and chief executive officer, will present at the 14th annual BIO...
Mehr lesen zu:
Exelixis Announces February 14 Webcast of Presentation at 14th Annual BIO CEO & Investor Conference
10.02. 41
TARRYTOWN, N.Y., Feb. 10, 2012 /PRNewswire/ --Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2011 financial...
Mehr lesen zu:
Regeneron Announces February 13, 2012 as Date of Full Year 2011 Financial and Operating Results Conference Call and Webcast
Seite: 1 2 3 4 5 ... Weiter>>